Clinical Trials Directory

Trials / Completed

CompletedNCT02894281

Pupillometry Dynamic Measures in Patients Without Ocular or Neurological Disease

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Retrobulbar optic neuritis (NORB) is the damage to the optic nerve caused by inflammation. It causes a rapidly progressive and painful visual loss, often among young subjects. Diagnosis confirmation is important to start proper treatment, because a NORB is often the first symptom of multiple sclerosis. This diagnosis, based on a set of arguments, is difficult to define by a non-expert ophthalmologist. The pupillary light reflex is a way to test the visual afferent pathways. If it is subject to a large inter-individual variability, the dynamics of the pupillary light reflex and its latency are more reproducible. An easy way to study the dynamics of the pupillary light reflex is to study the pupillary cycle time (PCT). In the case of NORB, elongation of the conduction in the visual afferent pathways related to demyelination plate increases the latency of the pupillary light reflex and decreases the frequency of the PCT. Our hypothesis is that PCT dynamics measures would be a reliable indicator and easy to evaluate some pathologies affecting the integrity of the nerve. The validation of a decrease in the frequency of the PCT in NORB, compared to the frequency observed in subjects ophthalmological or neurological disease, could help developing methods to study the conduction of the visual pathways with portable devices used during the standard ophthalmologic consultation and quickly orientate patients to specialized centers.

Conditions

Interventions

TypeNameDescription
DEVICEpupillary light reflexmeasure with infra-red cameras

Timeline

Start date
2016-06-01
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2016-09-09
Last updated
2017-07-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02894281. Inclusion in this directory is not an endorsement.